Loxo Oncology Inc (NASDAQ:LOXO)

129.51
Delayed Data
As of Apr 24
 -3.55 / -2.67%
Today’s Change
42.11
Today|||52-Week Range
138.54
+53.85%
Year-to-Date

Today’s Trading

Previous close133.06
Today’s open133.67
Day’s range128.78 - 135.00
Volume302,266
Average volume (3 months)398,747
Market cap$3.9B
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)-53.47%
Earnings growth (this year)+111.96%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales110.80
Price/Book10.23

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-1.13-2.10%
SRPTSarepta Therapeutics...-1.91-2.44%
IRWDIronwood Pharmaceuti...-0.55-3.14%
PRTAProthena Corporation...-0.41-3.61%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting dateMay 17, 2018
EPS forecast (this quarter)-$1.24
Annual revenue (last year)$21.3M
Annual profit (last year)-$148.9M
Net profit margin-698.95%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Josh Bilenker
Executive Director-
Business Operations
Sara Slifka
Corporate headquarters
Stamford, Connecticut

Forecasts